AbbVie ABBV
NYSE ABBV
$264.94 +3.11 (+1.19%)
As of: Aug 21, 2026 · 3:59 PM EDT

AbbVie (ABBV) EBT Margin (QoQ) (2012 - 2026)

AbbVie (ABBV) EBT Margin (QoQ) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 1,825.00
Mar 31, 2026 -913.00
Dec 31, 2025 1,153.00
Sep 30, 2025 -555.00
Jun 30, 2025 -237.00
Mar 31, 2025 2,747.00
Dec 31, 2024 -2,944.00
Sep 30, 2024 -43.00
Jun 30, 2024 58.00
Mar 31, 2024 578.00
Dec 31, 2023 -555.00
Sep 30, 2023 -480.00
Jun 30, 2023 1,494.00
Mar 31, 2023 -1,572.00
Dec 31, 2022 -1,010.00
Sep 30, 2022 2,159.00
Jun 30, 2022 -2,830.00
Mar 31, 2022 772.00
Dec 31, 2021 298.00
Sep 30, 2021 1,738.00